GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Deltex Medical Group PLC (LSE:DEMG) » Definitions » LT-Debt-to-Total-Asset

Deltex Medical Group (LSE:DEMG) LT-Debt-to-Total-Asset : 0.20 (As of Jun. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Deltex Medical Group LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Deltex Medical Group's long-term debt to total assests ratio for the quarter that ended in Jun. 2024 was 0.20.

Deltex Medical Group's long-term debt to total assets ratio increased from Jun. 2023 (0.19) to Jun. 2024 (0.20). It may suggest that Deltex Medical Group is progressively becoming more dependent on debt to grow their business.


Deltex Medical Group LT-Debt-to-Total-Asset Historical Data

The historical data trend for Deltex Medical Group's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deltex Medical Group LT-Debt-to-Total-Asset Chart

Deltex Medical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.21 0.23 0.23 0.21 0.30

Deltex Medical Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.21 0.19 0.30 0.20

Deltex Medical Group LT-Debt-to-Total-Asset Calculation

Deltex Medical Group's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )/Total Assets (A: Dec. 2023 )
=1.784/5.932
=0.30

Deltex Medical Group's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (Q: Jun. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Jun. 2024 )/Total Assets (Q: Jun. 2024 )
=1.121/5.5
=0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Deltex Medical Group  (LSE:DEMG) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Deltex Medical Group LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Deltex Medical Group's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Deltex Medical Group Business Description

Traded in Other Exchanges
Address
Terminus Road, Chichester, West Sussex, GBR, PO19 8TX
Deltex Medical Group PLC is a British manufacturer of Fluid Management devices, which include the ODM and now ODM+ haemodynamic monitoring systems. The company has developed the gold standard for haemodynamic monitoring with oesophageal Doppler technology, which is marketed as TrueVue Doppler and often generically referred to by clinicians as ODM. The company's initial and principal technology is Doppler-based ultrasound oesophageal haemodynamic monitoring.

Deltex Medical Group Headlines

No Headlines